TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.36−0.01 (-0.73%)
Close on Nov 19, 2026Market cap $86.67MP/E –Yield –
TuHURA Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for TuHURA Biosciences
TuHURA Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?